19-11030816-C-T

Variant summary

Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate

The NM_003072.5(SMARCA4):​c.3469C>T​(p.Arg1157Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1157G) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SMARCA4
NM_003072.5 missense

Scores

16
2
1

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 1.41
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 13 ACMG points.

PM1
In a domain Helicase C-terminal (size 162) in uniprot entity SMCA4_HUMAN there are 12 pathogenic changes around while only 0 benign (100%) in NM_003072.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr19-11030816-C-G is described in Lovd as [Pathogenic].
PP2
Missense variant in the SMARCA4 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 59 curated pathogenic missense variants (we use a threshold of 10). The gene has 56 curated benign missense variants. Gene score misZ: 6.8459 (above the threshold of 3.09). Trascript score misZ: 8.7957 (above the threshold of 3.09). GenCC associations: The gene is linked to uterine corpus sarcoma, Coffin-Siris syndrome 1, intellectual disability, autosomal dominant 16, rhabdoid tumor predisposition syndrome 2, familial rhabdoid tumor, hereditary nonpolyposis colon cancer, Coffin-Siris syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.94
PP5
Variant 19-11030816-C-T is Pathogenic according to our data. Variant chr19-11030816-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2703875.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 35 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 36 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000344626.10 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 35 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000643549.1 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 35 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000541122.6 linkc.3469C>T p.Arg1157Trp missense_variant Exon 26 of 35 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 34 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.3469C>T p.Arg1157Trp missense_variant Exon 25 of 34 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.3469C>T p.Arg1157Trp missense_variant Exon 26 of 35 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.2881C>T p.Arg961Trp missense_variant Exon 22 of 32 ENSP00000496004.1 A0A2R8YGG3
SMARCA4ENST00000644963.1 linkc.2113C>T p.Arg705Trp missense_variant Exon 18 of 28 ENSP00000495599.1 A0A2R8YG32
SMARCA4ENST00000644065.1 linkc.2194C>T p.Arg732Trp missense_variant Exon 18 of 27 ENSP00000493615.1 A0A2R8Y440
SMARCA4ENST00000642350.1 linkc.1954C>T p.Arg652Trp missense_variant Exon 17 of 27 ENSP00000495355.1 A0A2R8Y6N0
SMARCA4ENST00000643857.1 linkc.1822C>T p.Arg608Trp missense_variant Exon 16 of 25 ENSP00000494159.1 A0A2R8Y526

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1455956
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
723748
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Rhabdoid tumor predisposition syndrome 2 Pathogenic:1
Dec 18, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1157 of the SMARCA4 protein (p.Arg1157Trp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMARCA4 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg1157 amino acid residue in SMARCA4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22426308; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.30
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.96
D;.;D;.;.;.;.;.;.;.;D;.;.;.;.;.;D;D;.;.;.
Eigen
Pathogenic
0.79
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
1.0
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.81
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.87
D
MutationAssessor
Pathogenic
4.1
H;.;.;.;H;H;.;H;H;H;H;H;H;H;H;H;.;.;.;.;.
PrimateAI
Pathogenic
0.91
D
PROVEAN
Pathogenic
-7.0
D;.;.;.;.;.;.;.;.;.;D;.;D;.;D;.;.;D;.;.;.
REVEL
Pathogenic
0.76
Sift
Pathogenic
0.0
D;.;.;.;.;.;.;.;.;.;D;.;D;.;D;.;.;D;.;.;.
Sift4G
Pathogenic
0.0
D;.;.;.;.;.;.;.;.;.;D;.;D;D;D;D;D;D;.;.;.
Polyphen
1.0
D;.;D;.;.;.;.;.;.;.;D;.;.;.;.;.;.;D;.;.;.
Vest4
0.97
MutPred
0.77
Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);Loss of methylation at R1157 (P = 0.0112);.;Loss of methylation at R1157 (P = 0.0112);.;.;.;
MVP
0.89
MPC
2.8
ClinPred
1.0
D
GERP RS
4.6
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.8
Varity_R
0.96
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-11141492; COSMIC: COSV60789213; COSMIC: COSV60789213; API